RadNet, Inc. (RDNT) 10-Year Financial Performance & Capital Metrics

RDNT • • Industrial / General

HealthcareDiagnostics & ResearchClinical Laboratory ServicesSpecialized Testing Laboratories

AboutRadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.Show more

Revenue $1.83B +13.2%
EBITDA $242M -15.9%
Net Income $3M -8.2%
EPS (Diluted) 0.04 -20.6%
Gross Margin 13.62% -0.6%
EBITDA Margin 13.25% -25.7%
Operating Margin 5.72% -6.3%
Net Margin 0.15% -18.9%
ROE 0.29% -38.5%
ROIC 3.84% -0.4%
Debt/Equity 1.53 -16.8%
Interest Coverage 1.31 -14.4%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓High quality earnings: Operating CF exceeds net income

✗Weaknesses

✗Weak 3Y average ROE of 1.1%
✗Profits declining 28.3% over 5 years
✗Shares diluted 15.6% in last year
✗Thin 5Y average net margin of 0.3%

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y9.81%

5Y9.65%

3Y11.64%

TTM11.09%

Profit (Net Income) CAGR

10Y7.34%

5Y-28.32%

3Y-51.66%

TTM-188.08%

EPS CAGR

10Y2.23%

5Y-39.72%

3Y-56.68%

TTM-174.01%

ROCE

10Y Avg4.87%

5Y Avg3.87%

3Y Avg3.78%

Latest4.14%

Peer Comparison

Specialized Testing Laboratories

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
RDNTRadNet, Inc.	5.64B	72.99	1951.60	13.18%	-0.65%	-0.97%	0.8%	1.53
IDXXIDEXX Laboratories, Inc.	56.86B	712.12	66.74	6.46%	24.65%	65.81%	1.4%	0.62
CDNACareDx, Inc	1.06B	20.57	22.12	19.07%	16.97%	19.53%	2.98%	0.07
TRIBTrinity Biotech plc	13.23M	0.71	-0.40	8.31%	-73.78%
NEOGNeogen Corporation	2.06B	9.46	-1.88	-3.2%	-68.47%	-28.64%		0.44
STRRStar Equity Holdings, Inc.	38.07M	10.96	-2.76	-66.93%	-5.36%	-8.98%		0.03
BGLCBioNexus Gene Lab Corp.	8.72M	3.69	-4.10	-2.66%	-24.27%	-33.7%		0.03
NEONeoGenomics, Inc.	1.66B	12.83	-4.14	11.65%	-16%	-13.54%		0.67

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	809.63M	884.53M	922.19M	975.15M	1.15B	1.07B	1.32B	1.43B	1.62B	1.83B
Revenue Growth %	0.13%	0.09%	0.04%	0.06%	0.18%	-0.07%	0.23%	0.09%	0.13%	0.13%
Cost of Goods Sold+	708.29M	775.8M	802.38M	867.55M	999.69M	965.9M	1.12B	1.26B	1.4B	1.58B
COGS % of Revenue	0.87%	0.88%	0.87%	0.89%	0.87%	0.9%	0.85%	0.88%	0.86%	0.86%
Gross Profit+	101.34M	108.73M	119.81M	107.6M	154.49M	105.94M	191.8M	165.72M	221.39M	249.12M
Gross Margin %	0.13%	0.12%	0.13%	0.11%	0.13%	0.1%	0.15%	0.12%	0.14%	0.14%
Gross Profit Growth %	-0.12%	0.07%	0.1%	-0.1%	0.44%	-0.31%	0.81%	-0.14%	0.34%	0.13%
Operating Expenses+	60.61M	66.61M	66.8M	72.9M	84.61M	70.25M	109.25M	119.35M	122.69M	144.49M
OpEx % of Revenue	0.07%	0.08%	0.07%	0.07%	0.07%	0.07%	0.08%	0.08%	0.08%	0.08%
Selling, General & Admin	745K	2.88M	1.82M	0	0	0	0	0	0	0
SG&A % of Revenue	0%	0%	0%	-	-	-	-	-	-	-
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	2.85M	2.61M	258K	181K	84.61M	70.25M	109.25M	119.35M	122.69M	144.49M
Operating Income+	39.12M	38.48M	50.05M	30.89M	69.88M	35.68M	82.55M	46.36M	98.7M	104.62M
Operating Margin %	0.05%	0.04%	0.05%	0.03%	0.06%	0.03%	0.06%	0.03%	0.06%	0.06%
Operating Income Growth %	-0.27%	-0.02%	0.3%	-0.38%	1.26%	-0.49%	1.31%	-0.44%	1.13%	0.06%
EBITDA+	99.73M	105.09M	116.85M	103.78M	217.33M	190.39M	253.22M	231.09M	288.19M	242.46M
EBITDA Margin %	0.12%	0.12%	0.13%	0.11%	0.19%	0.18%	0.19%	0.16%	0.18%	0.13%
EBITDA Growth %	-0.11%	0.05%	0.11%	-0.11%	1.09%	-0.12%	0.33%	-0.09%	0.25%	-0.16%
D&A (Non-Cash Add-back)	60.61M	66.61M	66.8M	72.9M	147.45M	154.71M	170.66M	184.72M	189.49M	137.84M
EBIT	56.33M	42.12M	53.01M	34.7M	77.71M	45.03M	107.71M	93.81M	103.29M	124.71M
Net Interest Income+	-41.68M	-43.45M	-40.62M	-43.46M	-48.04M	-45.88M	-48.83M	-50.84M	-64.48M	-79.85M
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	41.68M	43.45M	40.62M	43.46M	48.04M	45.88M	48.83M	50.84M	64.48M	79.85M
Other Income/Expense	-24.47M	-26.04M	-23.66M	7.64M	-40.21M	-36.54M	-23.68M	-3.39M	-59.89M	-59.76M
Pretax Income+	14.64M	12.44M	26.39M	38.53M	29.67M	-854K	58.88M	42.97M	38.81M	44.86M
Pretax Margin %	0.02%	0.01%	0.03%	0.04%	0.03%	-0%	0.04%	0.03%	0.02%	0.02%
Income Tax+	6.01M	4.43M	24.31M	394K	6.23M	895K	14.56M	9.36M	8.47M	6.03M
Effective Tax Rate %	0.53%	0.58%	0%	0.84%	0.5%	17.38%	0.42%	0.25%	0.08%	0.06%
Net Income+	7.71M	7.23M	53K	32.24M	14.76M	-14.84M	24.73M	10.65M	3.04M	2.79M
Net Margin %	0.01%	0.01%	0%	0.03%	0.01%	-0.01%	0.02%	0.01%	0%	0%
Net Income Growth %	4.6%	-0.06%	-0.99%	607.36%	-0.54%	-2.01%	2.67%	-0.57%	-0.71%	-0.08%
Net Income (Continuing)	8.64M	8M	2.08M	38.13M	23.44M	-1.75M	44.32M	33.61M	30.34M	38.84M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	3.88M	3.57M	8.37M	73.07M	81.45M	92.56M	117.25M	158.46M	182.66M	231.1M
EPS (Diluted)+	0.17	0.15	0.00	0.66	0.47	-0.29	0.46	0.17	0.05	0.04
EPS Growth %	4.67%	-0.12%	-0.99%	-	-0.29%	-1.62%	2.59%	-0.63%	-0.72%	-0.21%
EPS (Basic)	0.18	0.16	0.00	0.67	0.47	-0.29	0.47	0.19	0.05	0.04
Diluted Shares Outstanding	45.17M	46.66M	47.4M	48.68M	50.24M	50.89M	53.42M	57.32M	64.66M	74.76M
Basic Shares Outstanding	43.81M	46.24M	46.88M	48.11M	49.67M	50.89M	52.5M	56.29M	63.58M	73.04M
Dividend Payout Ratio	0.09%	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	230.52M	217.91M	235.35M	208.69M	241.84M	270.42M	324.26M	367.18M	579.28M	1.02B
Cash & Short-Term Investments	446K	20.64M	51.32M	10.39M	40.16M	102.02M	134.61M	127.83M	342.57M	740.02M
Cash Only	446K	20.64M	51.32M	10.39M	40.16M	102.02M	134.61M	127.83M	342.57M	740.02M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	167.66M	166.64M	157.86M	149.51M	156M	135.42M	140.45M	185.33M	189.05M	227.69M
Days Sales Outstanding	75.58	68.76	62.48	55.96	49.34	46.12	38.98	47.3	42.68	45.42
Inventory	22.28M	2.2M	0	2.5M	2.04M	0	0	0	0	0
Days Inventory Outstanding	11.48	1.04	-	1.05	0.75	-	-	-	-	-
Other Current Assets	22.28M	2.2M	0	2.5M	-1.38M	0	0	54.02M	47.66M	51.54M
Total Non-Current Assets+	607.91M	631.56M	633.63M	900.64M	1.4B	1.52B	1.73B	2.07B	2.11B	2.27B
Property, Plant & Equipment	256.72M	247.72M	244.3M	345.73M	812.22M	883M	1.07B	1.17B	1.2B	1.33B
Fixed Asset Turnover	3.15x	3.57x	3.77x	2.82x	1.42x	1.21x	1.23x	1.22x	1.35x	1.37x
Goodwill	239.41M	239.55M	256.78M	418.09M	440.98M	472.88M	513.82M	677.66M	679.46M	710.66M
Intangible Assets	45.25M	42.68M	40.42M	40.59M	42.99M	52.39M	56.6M	106.23M	90.61M	81.35M
Long-Term Investments	33.58M	43.51M	52.44M	37.97M	34.47M	34.53M	42.23M	57.89M	92.71M	104.06M
Other Non-Current Assets	8.26M	7.74M	8.84M	26.75M	38.55M	38.75M	38.17M	-160.86M	47.98M	36.84M
Total Assets+	838.43M	849.48M	868.98M	1.11B	1.65B	1.79B	2.06B	2.43B	2.69B	3.29B
Asset Turnover	0.97x	1.04x	1.06x	0.88x	0.70x	0.60x	0.64x	0.59x	0.60x	0.56x
Asset Growth %	0.13%	0.01%	0.02%	0.28%	0.48%	0.09%	0.15%	0.18%	0.11%	0.22%
Total Current Liabilities+	157.65M	155.34M	191.61M	239.52M	326.05M	398.11M	374.78M	466.72M	437.45M	479.71M
Accounts Payable	52.3M	40.95M	28.54M	68.04M	64.3M	70.07M	86.46M	102.68M	122.89M	96.45M
Days Payables Outstanding	26.95	19.27	12.98	28.63	23.48	26.48	28.09	29.64	32.15	22.27
Short-Term Debt	22.38M	26.56M	34.09M	39.27M	104.18M	39.79M	11.16M	12.4M	17.97M	24.69M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	52.95M	-1.56M	-1.15M	-1.88M	49.76M	14.01M	23.53M	227.94M	164.66M	255.01M
Current Ratio	1.46x	1.40x	1.23x	0.87x	0.74x	0.68x	0.87x	0.79x	1.32x	2.12x
Quick Ratio	1.32x	1.39x	1.23x	0.86x	0.74x	0.68x	0.87x	0.79x	1.32x	2.12x
Cash Conversion Cycle	60.12	50.53	-	28.39	26.6	-	-	-	-	-
Total Non-Current Liabilities+	644.32M	642.08M	607.45M	669.56M	1.09B	1.13B	1.34B	1.48B	1.44B	1.67B
Long-Term Debt	599.91M	609.45M	572.37M	626.51M	652.7M	612.91M	743.5M	839.34M	812.07M	991.57M
Capital Lease Obligations	6.38M	2.73M	2.67M	6.5M	424.19M	463.84M	577.67M	604.12M	605.1M	655.98M
Deferred Tax Liabilities	0	55.33M	36.69M	42.88M	158.63M	181.94M	195.69M	9.26M	15.78M	22.23M
Other Non-Current Liabilities	36.71M	29.91M	32.41M	36.55M	9.53M	53.49M	16.36M	23.02M	6.72M	3.79M
Total Liabilities	801.97M	797.42M	799.05M	909.08M	1.41B	1.53B	1.71B	1.94B	1.88B	2.15B
Total Debt+	640.73M	638.73M	612.99M	672.28M	1.25B	1.18B	1.4B	1.51B	1.49B	1.73B
Net Debt	640.28M	618.09M	561.67M	661.89M	1.21B	1.08B	1.26B	1.39B	1.15B	988.84M
Debt / Equity	17.57x	12.27x	8.77x	3.36x	5.34x	4.59x	4.04x	3.08x	1.83x	1.53x
Debt / EBITDA	6.42x	6.08x	5.25x	6.48x	5.73x	6.22x	5.52x	6.55x	5.17x	7.13x
Net Debt / EBITDA	6.42x	5.88x	4.81x	6.38x	5.55x	5.69x	4.99x	6.00x	3.99x	4.08x
Interest Coverage	0.94x	0.89x	1.23x	0.71x	1.45x	0.78x	1.69x	0.91x	1.53x	1.31x
Total Equity+	36.46M	52.05M	69.92M	200.25M	233.14M	258.3M	346.16M	491.45M	813.36M	1.13B
Equity Growth %	3.74%	0.43%	0.34%	1.86%	0.16%	0.11%	0.34%	0.42%	0.66%	0.39%
Book Value per Share	0.81	1.12	1.48	4.11	4.64	5.08	6.48	8.57	12.58	15.16
Total Shareholders' Equity	32.58M	48.49M	61.56M	127.18M	151.69M	165.74M	228.9M	333M	630.7M	902.31M
Common Stock	4K	4K	5K	5K	5K	5K	5K	6K	7K	7K
Retained Earnings	-164.57M	-150.5M	-150.16M	-117.92M	-103.16M	-118M	-93.27M	-82.62M	-79.58M	-76.78M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-153K	306K	-548K	2.26M	-8.03M	-24.05M	-20.42M	-20.68M	-12.48M	-9.06M
Minority Interest	3.88M	3.57M	8.37M	73.07M	81.45M	92.56M	117.25M	158.46M	182.66M	231.1M

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	67.04M	91.6M	141.19M	116.75M	104.32M	233.76M	149.49M	146.42M	220.86M	233.02M
Operating CF Margin %	0.08%	0.1%	0.15%	0.12%	0.09%	0.22%	0.11%	0.1%	0.14%	0.13%
Operating CF Growth %	0.1%	0.37%	0.54%	-0.17%	-0.11%	1.24%	-0.36%	-0.02%	0.51%	0.06%
Net Income	8.64M	8M	2.08M	38.13M	23.44M	-1.75M	44.32M	33.61M	30.34M	38.84M
Depreciation & Amortization	60.61M	66.61M	66.8M	72.9M	147.45M	154.71M	170.66M	184.72M	189.49M	198.39M
Stock-Based Compensation	7.65M	5.83M	6.79M	7.66M	8.73M	12.4M	25.2M	23.77M	26.79M	29.83M
Deferred Taxes	4.04M	3.45M	19.5M	-6.93M	0	0	-21.49M	13.36M	0	0
Other Non-Cash Items	31.6M	35.88M	24.71M	-13.35M	2.55M	13.53M	22.93M	-50.34M	14.52M	22.45M
Working Capital Changes	-45.5M	-28.17M	21.31M	18.35M	-77.85M	54.86M	-92.13M	-58.7M	-40.27M	-56.49M
Change in Receivables	-34.51M	-47.05M	-37.16M	2.15M	-17.48M	25.21M	-5.89M	-30.08M	2.65M	-21.77M
Change in Inventory	-18.01M	12.26M	-378K	-10.94M	0	0	-87.67M	0	0	0
Change in Payables	-3.65M	4.93M	36.18M	27.97M	17.32M	45.07M	9.91M	49.78M	15.09M	37.12M
Cash from Investing+	-96.8M	-65.45M	-78.28M	-146.75M	-99.47M	-126.24M	-221.51M	-246.95M	-201.47M	-233.07M
Capital Expenditures	-133.76M	-65.89M	-88.95M	-145.37M	-101.3M	-125.44M	-220.69M	-249.41M	-176.6M	-188.07M
CapEx % of Revenue	0.17%	0.07%	0.1%	0.15%	0.09%	0.12%	0.17%	0.17%	0.11%	0.1%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	37.49M	994K	8.43M	248K	1.95M	828K	625K	3.9M	83K	157K
Cash from Financing+	29.94M	-5.91M	-32.25M	-10.87M	24.95M	-45.56M	104.67M	93.65M	195.63M	397.95M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-729K	-492K	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	4.87M	-1.6M	6.32M	1.03M	3.04M	-2.73M	9.71M	-893K	-6.2M	14.23M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-66.72M	25.71M	52.24M	-28.62M	3.02M	108.32M	-71.2M	-103M	44.26M	44.95M
FCF Margin %	-0.08%	0.03%	0.06%	-0.03%	0%	0.1%	-0.05%	-0.07%	0.03%	0.02%
FCF Growth %	-7.78%	1.39%	1.03%	-1.55%	1.11%	34.88%	-1.66%	-0.45%	1.43%	0.02%
FCF per Share	-1.48	0.55	1.10	-0.59	0.06	2.13	-1.33	-1.80	0.68	0.60
FCF Conversion (FCF/Net Income)	8.70x	12.67x	2663.91x	3.62x	7.07x	-15.75x	6.05x	13.75x	72.56x	83.43x
Interest Paid	36.03M	37.49M	34.2M	37.02M	46.25M	39.52M	29.04M	39.15M	64.69M	84.6M
Taxes Paid	1.78M	2.8M	4.94M	4.93M	5.88M	5.07M	1.95M	587K	1.59M	4.17M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	34.91%	16.34%	0.09%	23.87%	6.81%	-6.04%	8.18%	2.54%	0.47%	0.29%
Return on Invested Capital (ROIC)	4.58%	4.29%	5.77%	3.1%	4.56%	1.93%	4.2%	1.99%	3.86%	3.84%
Gross Margin	12.52%	12.29%	12.99%	11.03%	13.38%	9.88%	14.58%	11.59%	13.69%	13.62%
Net Margin	0.95%	0.82%	0.01%	3.31%	1.28%	-1.38%	1.88%	0.74%	0.19%	0.15%
Debt / Equity	17.57x	12.27x	8.77x	3.36x	5.34x	4.59x	4.04x	3.08x	1.83x	1.53x
Interest Coverage	0.94x	0.89x	1.23x	0.71x	1.45x	0.78x	1.69x	0.91x	1.53x	1.31x
FCF Conversion	8.70x	12.67x	2663.91x	3.62x	7.07x	-15.75x	6.05x	13.75x	72.56x	83.43x
Revenue Growth	12.83%	9.25%	4.26%	5.74%	18.36%	-7.13%	22.69%	8.74%	13.05%	13.18%

Revenue by Segment

	2018	2019	2020	2021	2022	2023	2024
Commercial Insurance1	-	642.34M	584.03M	743.46M	785.13M	897.95M	1.02B
Commercial Insurance1 Growth	-	-	-9.08%	27.30%	5.60%	14.37%	13.41%
Medicare1	-	237.43M	217.93M	280.91M	311.12M	363.86M	410.07M
Medicare1 Growth	-	-	-8.21%	28.90%	10.76%	16.95%	12.70%
Capitation Arrangements	-	125.94M	140.12M	148.33M	152.04M	153.43M	136.57M
Capitation Arrangements Growth	-	-	11.26%	5.86%	2.50%	0.91%	-10.99%
Health Care, Other	-	24.55M	23.3M	13.85M	19.43M	20.11M	46.72M
Health Care, Other Growth	-	-	-5.12%	-40.55%	40.26%	3.52%	132.33%
Medicaid1	-	28.28M	25.62M	34.73M	38.28M	43.17M	44.74M
Medicaid1 Growth	-	-	-9.42%	35.57%	10.22%	12.79%	3.62%
Workers' Compensation/Personal Injury1	-	42.79M	33.48M	44.23M	51.34M	47.36M	43.67M
Workers' Compensation/Personal Injury1 Growth	-	-	-21.77%	32.13%	16.06%	-7.74%	-7.81%
Health Care, Management Service	-	11.66M	11.25M	19.63M	22.23M	17.94M	24.68M
Health Care, Management Service Growth	-	-	-3.48%	74.44%	13.27%	-19.33%	37.58%
Health Care, Patient Service Other	-	23.86M	25.31M	19.4M	31.85M	42.25M	-
Health Care, Patient Service Other Growth	-	-	6.08%	-23.37%	64.19%	32.65%	-
Software and Teleradiology	-	-	-	-	14.24M	18.08M	-
Software and Teleradiology Growth	-	-	-	-	-	27.00%	-
Health Care, Patient Service	-	1.03B	931.72M	1.17B	-	-	-
Health Care, Patient Service Growth	-	-	-9.39%	25.22%	-	-	-
Imaging On Call	-	17.32M	10.8M	10.53M	-	-	-
Imaging On Call Growth	-	-	-37.65%	-2.53%	-	-	-
Investment Advisory, Management and Administrative Service	13.8M	-	-	-	-	-	-
Investment Advisory, Management and Administrative Service Growth	-	-	-	-	-	-	-
License	248K	-	-	-	-	-	-
License Growth	-	-	-	-	-	-	-

Revenue by Geography

	2018	2019	2020	2021	2022	2023	2024
UNITED STATES	-	-	-	-	-	-	1.8B
UNITED STATES Growth	-	-	-	-	-	-	-
Other Countries	-	-	-	-	-	-	2.88M
Other Countries Growth	-	-	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

RadNet, Inc. (RDNT) reported $1.97B in revenue for fiscal year 2024. This represents a 218% increase from $619.8M in 2011.

RadNet, Inc. (RDNT) grew revenue by 13.2% over the past year. This is steady growth.

RadNet, Inc. (RDNT) reported a net loss of $12.7M for fiscal year 2024.

Dividend & Returns

RadNet, Inc. (RDNT) has a return on equity (ROE) of 0.3%. This is below average, suggesting room for improvement.

RadNet, Inc. (RDNT) generated $52.1M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...